MoonLake Immunotherapeutics MLTX Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from MoonLake Immunotherapeutics’s reported figures.
Plus components not separately reported this period.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's total debt?
- MoonLake Immunotherapeutics (MLTX) reported total debt of $100.8M in Q1 2026.
- How has MoonLake Immunotherapeutics's total debt changed year-over-year?
- MoonLake Immunotherapeutics's total debt increased by 33.3% year-over-year, from $75.6M to $100.8M.
- What is the long-term trend for MoonLake Immunotherapeutics's total debt?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's total debt has grown at a 48.8% compound annual growth rate (CAGR), from $15.44M to $75.71M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.